BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2530679)

  • 1. Global control of hepatitis B virus (HBV).
    Tandon BN
    Trop Gastroenterol; 1989; 10(3):131-2. PubMed ID: 2530679
    [No Abstract]   [Full Text] [Related]  

  • 2. Public health control of HBV: worldwide HBV vaccination programme.
    Gust I
    Prog Clin Biol Res; 1991; 364():333-42. PubMed ID: 1826954
    [No Abstract]   [Full Text] [Related]  

  • 3. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S
    Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in immunization against hepatitis B.
    Zuckerman AJ
    Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccines.
    Zuckerman AJ
    Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hepatitis B virus vaccine in Africa: rationale and practical approaches for effective utilization.
    Prince AM
    IARC Sci Publ; 1984; (63):337-54. PubMed ID: 6242151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the global elimination of hepatitis B virus transmission.
    Goldstein ST; Fiore AE
    J Pediatr; 2001 Sep; 139(3):343-5. PubMed ID: 11562609
    [No Abstract]   [Full Text] [Related]  

  • 13. Worldwide immunization program targets hepatitis B and liver cancer.
    Newman ME
    J Natl Cancer Inst; 1991 May; 83(10):666-8. PubMed ID: 2023266
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B vaccine: a safe and effective method for preventing infection with hepatitis B and delta agent.
    Chorba T
    N C Med J; 1986 Jul; 47(7):343-5. PubMed ID: 2942784
    [No Abstract]   [Full Text] [Related]  

  • 15. New combined hepatitis A and B vaccine. Immunisation is only part of preventing infectious disease.
    Kasianos G
    BMJ; 1998 Apr; 316(7140):1317. PubMed ID: 9599052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of hepatitis A and hepatitis B with vaccination].
    Buisson Y; Meyran M
    Bull Acad Natl Med; 1995 Feb; 179(2):367-74; discussion 373-5. PubMed ID: 7614064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk].
    Lavezzi M; Donati A; Davi D; Carpanelli MC; Farinelli S; Soracco E
    Quad Sclavo Diagn; 1987 Jun; 23(2):164-8. PubMed ID: 2967519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An affordable multideterminant plasma-derived hepatitis B virus vaccine.
    Prince AM; Vnek J; Brotman B
    IARC Sci Publ; 1984; (63):355-72. PubMed ID: 6085626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.